Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer

November 14, 2016 updated by: Stefano Uccella, Università degli Studi dell'Insubria

Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer: a Multi-centric Study

The investigators sought to retrospectively assess whether the use of a intrauterine device to manipulate the uterus does affect the long-term oncologic outcomes of patients operated by laparoscopy for endometrial cancer

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators retrospectively collected data regarding patients who received operation by laparoscopy for presumed clinical stage I endometrial cancer. The subjects were then stratified according to the use or not of the uterine manipulator. The investigators also considered the actual type of manipulator used. Then disease-free, disease-specific and overall survival were evaluated, as well as all the possible factors associated with prognosis.

Data were retrieved from specifically designed research quality internal surgical databases, prospectively updated by trained residents on a regular basis, in order to capture all the possible surgical and follow-up data.

Study Type

Observational

Enrollment (Actual)

951

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women affected by early endometrial cancer

Description

Inclusion Criteria:

  • Clinical stage I endometrial cancer
  • Laparoscopic operation

Exclusion Criteria:

  • post-operative oncologic follow-up < 12 months
  • extra-uterine evidence of disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy with the use of a uterine manipulator
Patients were operated laparoscopically with the aid or not of an intrauterine probe to manipulate the uterus
NO MANIPULATOR
Patients who were operated for endometrial cancer by laparoscopy without the use of a uterine manipulator

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease recurrence
Time Frame: 4 years
Relapse of disease during follow-up
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
disease specific survival
Time Frame: 4 years
Kaplan Meyer curves and Log-rank test to explore disease-specific survival
4 years
overall survival
Time Frame: 4 years
Kaplan Meyer curves and Log-rank test to explore overall survival
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stefano Uccella, Università degli Studi dell'Insubria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

October 1, 2016

Study Registration Dates

First Submitted

October 22, 2016

First Submitted That Met QC Criteria

October 22, 2016

First Posted (Estimate)

October 25, 2016

Study Record Updates

Last Update Posted (Estimate)

November 15, 2016

Last Update Submitted That Met QC Criteria

November 14, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometrial Cancer

Clinical Trials on UTERINE MANIPULATOR

3
Subscribe